-
Product Insights
Likelihood of Approval Analysis for Mycosis Fungoides
Overview How likely is it that the drugs in Mycosis Fungoides will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Mycosis Fungoides Overview Mycosis fungoides is a rare type of non-Hodgkin lymphoma,...
-
Product Insights
Likelihood of Approval Analysis for Psoriatic Arthritis
Overview How likely is it that the drugs in Psoriatic Arthritis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Psoriatic Arthritis Overview Psoriatic arthritis is a form of arthritis that affects...
-
Product Insights
Likelihood of Approval Analysis for Dermatological Disorders
Overview How likely is it that the drugs in Dermatological Disorders will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Dermatological Disorders Overview Dermatological disorders are diseases or conditions that affect the...
-
Product Insights
Likelihood of Approval Analysis for Plaque Psoriasis (Psoriasis Vulgaris)
Overview How likely is it that the drugs in Plaque Psoriasis (Psoriasis Vulgaris) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Plaque Psoriasis (Psoriasis Vulgaris) Overview Plaque psoriasis, also known as...
-
Product Insights
Likelihood of Approval Analysis for Psoriasis
Overview How likely is it that the drugs in Psoriasis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Psoriasis Overview Psoriasis is a chronic autoimmune skin condition characterized by rapid proliferation...
-
Thematic Analysis
Patient Empowerment – Thematic Intelligence
Reasons to buy the ‘Patient Empowerment’ thematic intelligence report: Assess patients’ health literacy. Understand interactions between patients and HCPs. Capture patients’ opinions on patient empowerment in healthcare. Gain a deeper understanding of shared decision-making. Evaluate patients’ access to disease and treatment information. Explore the role of pharmaceutical companies in empowering patients. How is our ‘Patient Empowerment’ report unique from other reports in the market? This report combines information obtained from secondary sources and primary research with patients suffering from chronic...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Mufemilast in Ankylosing Spondylitis (Bekhterev’s Disease)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Mufemilast in Ankylosing Spondylitis (Bekhterev's Disease) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Mufemilast in Ankylosing Spondylitis (Bekhterev's Disease) Drug Details: Hemay-005...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – ARN-6039 in Multiple Sclerosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ARN-6039 in Multiple Sclerosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ARN-6039 in Multiple Sclerosis Drug Details: BOS-172767 (ARN-6039) is under development for...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – ARN-6039 in Psoriasis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ARN-6039 in Psoriasis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ARN-6039 in Psoriasis Drug Details: BOS-172767 (ARN-6039) is under development for the treatment...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – ARN-6039 in Neuromyelitis Optica (Devic’s Syndrome)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ARN-6039 in Neuromyelitis Optica (Devic's Syndrome) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ARN-6039 in Neuromyelitis Optica (Devic's Syndrome) Drug Details: BOS-172767 (ARN-6039)...